You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

peritoneal malignant mesothelioma

Showing 1 - 25 of 6,556
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Peritoneal Malignant Mesothelioma Trial in Rotterdam (Intraperitoneal Paclitaxel Solution (Ml))

Recruiting
  • Peritoneal Malignant Mesothelioma
  • Intraperitoneal Paclitaxel Solution (Ml)
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus Medical Center
Jul 7, 2022

Biphasic Mesothelioma, Epithelioid Mesothelioma, Peritoneal Malignant Mesothelioma Trial in Chicago (Pembrolizumab, Laboratory

Active, not recruiting
  • Biphasic Mesothelioma
  • +9 more
  • Pembrolizumab
  • +2 more
  • Chicago, Illinois
    University of Chicago
Apr 18, 2022

Histologic Prognostic Factors in Peritoneal Malignant

Recruiting
  • Peritoneal Malignant Mesothelioma
  • No intervention
  • Gent, Belgium
  • +5 more
Dec 31, 2021

Malignant Peritoneal Mesothelioma, Peritoneal Mesothelioma, Mesothelioma Trial in United States (Pemetrexed, Cisplatin,

Recruiting
  • Malignant Peritoneal Mesothelioma
  • +4 more
  • Chicago, Illinois
  • +10 more
Sep 21, 2023

Peritoneal Carcinomatosis, Peritoneal Mesothelioma, Ovarian Cancer Trial run by the NCI (Mitomycin C, Cisplatin, Heated

Recruiting
  • Peritoneal Carcinomatosis
  • +4 more
  • Mitomycin C
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 28, 2023

Mesothelioma, Peritoneal Mesothelioma Trial in Chicago (Nivolumab, Ipilimumab)

Recruiting
  • Mesothelioma
  • Peritoneal Mesothelioma
  • Chicago, Illinois
    The University of Chicago
Feb 14, 2022

Peritoneal Mesothelioma, Peritoneal Carcinomatosis Trial in Montpellier (PIPAC, Cisplatin, Pemetrexed)

Recruiting
  • Peritoneal Mesothelioma
  • Peritoneal Carcinomatosis
  • PIPAC
  • +2 more
  • Montpellier, France
    Institut réginal du Cancer de Montpellier
Nov 3, 2021

Malignant Abdominal Tumor, Malignant Pelvic Tumor, Recurrent Colon Carcinoma Trial in Rochester (Cisplatin, Cytoreductive

Recruiting
  • Malignant Abdominal Neoplasm
  • +26 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 5, 2023

Lung Adenocarcinoma, Ovarian Cancer, Peritoneal Carcinoma Trial in Philadelphia (huCART-meso cells)

Recruiting
  • Lung Adenocarcinoma
  • +5 more
  • huCART-meso cells
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Dec 1, 2022

Microsatellite High Cancers, Peritoneal Mesothelioma, Extrapulmonary High Grade Trial in Houston (XmAb20717)

Recruiting
  • Microsatellite High Cancers
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 8, 2022

Peritoneal Malignant Mesothelioma Trial in United States (biological, drug, procedure)

Recruiting
  • Peritoneal Malignant Mesothelioma
  • Atezolizumab
  • +8 more
  • Phoenix, Arizona
  • +25 more
Feb 2, 2023

Peritoneal Mesothelioma, Fallopian Tube Adenocarcinoma, Adenocarcinoma of the Ovary Trial in United States (MCY-M11,

Terminated
  • Peritoneal Mesothelioma
  • +3 more
  • Rockville, Maryland
  • +3 more
Aug 30, 2021

Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer Trial in United States (PRO1184)

Recruiting
  • Ovarian Cancer
  • +8 more
  • Scottsdale, Arizona
  • +11 more
Jan 31, 2023

Study of Patients With Malignant Mesothelioma

Recruiting
  • Mesothelioma
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Apr 7, 2022

    Malignant Pleural Mesothelioma Trial (Proton beam therapy)

    Not yet recruiting
    • Malignant Pleural Mesothelioma
    • Proton beam therapy
    • (no location specified)
    Dec 14, 2022

    Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in

    Recruiting
    • Malignant Pleural Mesothelioma, Advanced
    • Oncolytic Adenovirus H101
    • Programmed death receptor-1 inhibitor
    • Tianjin, Tianjin, China
      Tianjin Medical Unversity Second Hospital
    Sep 2, 2023

    Mesothelioma Trial run by the National Cancer Institute (NCI) (LMB-100, ipilimumab)

    Recruiting
    • Mesothelioma
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jul 6, 2022

    Mesothelioma Trial run by the National Cancer Institute (NCI) (LMB-100, nab-paclitaxel)

    Completed
    Has Results
    • Mesothelioma
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jul 28, 2022

    Malignant Pleural Mesothelioma Trial in Cairo (Gemcitabine, supportive care)

    Not yet recruiting
    • Malignant Pleural Mesothelioma
    • Cairo, Egypt
      Ain Shams University Hospital
    Dec 20, 2022

    Malignant Pleural Mesothelioma, Mesothelioma Trial in Tampa (Cisplatin, Methotrexate, Gemcitabine)

    Active, not recruiting
    Has Results
    • Malignant Pleural Mesothelioma
    • Mesothelioma
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jan 5, 2023

    Ovarian Cancer, Cholangiocarcinoma Recurrent, Mesothelioma, Malignant Trial (SynKIR-110, Autologous T cells Transduced with

    Not yet recruiting
    • Ovarian Cancer
    • +2 more
    • SynKIR-110, Autologous T cells Transduced with Mesothelin KIR-CAR
    • (no location specified)
    Oct 5, 2022

    Malignant Pleural Mesothelioma Trial in Edegem, Ghent, Sint-Niklaas (Dendritic cell vaccination, Atezolizumab,

    Not yet recruiting
    • Malignant Pleural Mesothelioma
    • Dendritic cell vaccination
    • +2 more
    • Edegem, Antwerp, Belgium
    • +2 more
    Feb 28, 2023

    Mesotheliomas Pleural Trial in Amsterdam (Pembrolizumab, Lenvatinib)

    Recruiting
    • Mesotheliomas Pleural
    • Amsterdam, Noord-Holland, Netherlands
      Antoni van Leeuwenhoekziekenhuis (NKI-AVL)
    Jan 13, 2023

    Peritoneal Carcinomatosis, Pseudomyxoma Peritonei, Mesothelioma Peritoneum Trial in Montpellier (Cardiac coherence, Standard

    Recruiting
    • Peritoneal Carcinomatosis
    • +2 more
    • Cardiac coherence
    • Standard care
    • Montpellier, Hérault, France
      ICM
    Jan 16, 2023

    Advanced Malignant Pleural or Peritoneal Mesothelioma Trial (Talazoparib)

    Not yet recruiting
    • Advanced Malignant Pleural or Peritoneal Mesothelioma
    • (no location specified)
    Jul 8, 2020